Seeing Is Believing
FDMT is currently covered by 7 analysts with an average price target of $45.46. This is a potential upside of $22.21 (95.53%) from yesterday's end of day stock price of $23.25.
4D Molecular Therapeutics 's activity chart (see below) currently has 4 price targets and 31 ratings on display. The stock rating distribution of FDMT is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.86% with an average time for these price targets to be met of 88.43 days.
Highest price target for FDMT is $81, Lowest price target is $24, average price target is $45.46.
Most recent stock forecast was given by LUCA ISSI from RBC on 15-Apr-2024. First documented stock forecast 05-Jan-2021.
Currently out of the existing stock ratings of FDMT, 24 are a BUY (85.71%), 4 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
40
$15.75 (64.95%)
35
14 days ago
2/3 (66.67%)
$13.75 (52.38%)
29
Buy
63
$38.75 (159.79%)
70
28 days ago
0/3 (0%)
$32.99 (109.93%)
Buy
36
$11.75 (48.45%)
36
1 months 28 days ago
0/10 (0%)
$6.63 (22.57%)
Buy
81
$56.75 (234.02%)
68
2 months 22 days ago
0/2 (0%)
$52.76 (186.83%)
Buy
32
$7.75 (31.96%)
40
6 months 5 days ago
1/3 (33.33%)
$21.48 (204.18%)
104
What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?
Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?
Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?